Recent advances in DNA vaccine technology has brought about a promising
strategy for the control of viruses that contain surface membrane glycoproteins. This type
of vaccine involves the intramuscular injection of a bacterial plasmid containing a gene
encoding a viral protein. The strategy uses eukaryotic processing of the protein as...